
SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.

Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
Severe damage is seen at Gandi Hospital in Tehran, Iran, following US and Israeli joint strikes on March 2, 2026.
"The most serious risk is premature death," said one physician.
A senior Iranian health official on Tuesday accused the United States of deliberately targeting Iran's medical infrastructure amid a worsening shortage of critical medicines as President Donald Trump's illegal US-Israeli war of choice against Iran drags on.
Iran's pharmaceutical system is straining under US bombing, blockade, and sanctions that have severely disrupted trade and transportation in the Middle East nation of around 90 million people. Iranian officials say shortages of roughly 800 medicines—including dozens of essential drugs—are affecting the treatment of cancer and other serious illnesses.
“The enemy has identified medicine as one of the sensitive areas of the country, and is trying to denigrate and portray Iran’s conditions as unfavorable by releasing content in the press and social media," Deputy Health Minister Mahdi Pirsalehi, who also heads Iran's Food and Drug Administration, told Al Jazeera.
Pirsalehi has said that more than 50 factories and pharmacies have been damaged or destroyed by US and Israeli bombing during the six-month war. The attacks have exacerbated existing shortages.
One gastroenterologist and university professor in Tehran, who spoke to Al Jazeera on condition of anonymity, sounded the alarm on what she called a "staggering" rise in drug prices—including for domestically produced generic medications—caused in significant part by the US naval blockade.
“Reports that rotavirus vaccine imports have been halted because of the maritime blockade—and that influenza vaccines may soon face the same problem—represent a serious and alarming threat to nationwide efforts to prevent vaccine-preventable communicable diseases,” she said.
“Runaway inflation, poverty, and inadequate access to essential food groups among vulnerable populations, including infants, children, and pregnant women, signal the onset and spread of malnutrition,” she added, warning of the risk “of both communicable and noncommunicable diseases, creating a vicious cycle in which malnutrition develops and progressively worsens."
For ordinary Iranians, empty pharmacy shelves, delayed treatments, and prohibitively expensive prescription drugs have become the new normal.
One Iranian pharmaceutical company recently announced price increases for scores of drugs, including a 543% rise in the price of the Alzheimer's medication donepezil, a 308% higher cost for the antibiotic clarithromycin, and a 135% spike in acetaminophen and diphenhydramine syrups, according to reporting by Tasnim News Agency.
Dr. Hassan Nayeb Hashem told Deutsche Welle last month that "for many specific diseases, there is effectively no substitute" for prescribed drugs.
"If the medicine becomes inaccessible, patients can develop complications much sooner," he said. "The most serious risk is premature death."
One patient requiring testing for an abdominal and pelvic mass recently told Iran International that CT and MRI scans now cost over $100, even with Social Security insurance—the equivalent of a month's pay for many Iranians.
“How are we supposed to pay these costs with such meager incomes?” they asked.
A 33-year-old man said the exorbitant cost of dental treatment has left him without half of his teeth.
“I feel like I’m 60,” he said. “The bitter part is that this humiliating way of life has become normal for me.”
Another Iranian said they feared what would happen if anyone in their family got sick this winter.
“We’re stressed about where we would get the money for treatment," they said, "if God forbid we or our children even catch a cold."
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
A senior Iranian health official on Tuesday accused the United States of deliberately targeting Iran's medical infrastructure amid a worsening shortage of critical medicines as President Donald Trump's illegal US-Israeli war of choice against Iran drags on.
Iran's pharmaceutical system is straining under US bombing, blockade, and sanctions that have severely disrupted trade and transportation in the Middle East nation of around 90 million people. Iranian officials say shortages of roughly 800 medicines—including dozens of essential drugs—are affecting the treatment of cancer and other serious illnesses.
“The enemy has identified medicine as one of the sensitive areas of the country, and is trying to denigrate and portray Iran’s conditions as unfavorable by releasing content in the press and social media," Deputy Health Minister Mahdi Pirsalehi, who also heads Iran's Food and Drug Administration, told Al Jazeera.
Pirsalehi has said that more than 50 factories and pharmacies have been damaged or destroyed by US and Israeli bombing during the six-month war. The attacks have exacerbated existing shortages.
One gastroenterologist and university professor in Tehran, who spoke to Al Jazeera on condition of anonymity, sounded the alarm on what she called a "staggering" rise in drug prices—including for domestically produced generic medications—caused in significant part by the US naval blockade.
“Reports that rotavirus vaccine imports have been halted because of the maritime blockade—and that influenza vaccines may soon face the same problem—represent a serious and alarming threat to nationwide efforts to prevent vaccine-preventable communicable diseases,” she said.
“Runaway inflation, poverty, and inadequate access to essential food groups among vulnerable populations, including infants, children, and pregnant women, signal the onset and spread of malnutrition,” she added, warning of the risk “of both communicable and noncommunicable diseases, creating a vicious cycle in which malnutrition develops and progressively worsens."
For ordinary Iranians, empty pharmacy shelves, delayed treatments, and prohibitively expensive prescription drugs have become the new normal.
One Iranian pharmaceutical company recently announced price increases for scores of drugs, including a 543% rise in the price of the Alzheimer's medication donepezil, a 308% higher cost for the antibiotic clarithromycin, and a 135% spike in acetaminophen and diphenhydramine syrups, according to reporting by Tasnim News Agency.
Dr. Hassan Nayeb Hashem told Deutsche Welle last month that "for many specific diseases, there is effectively no substitute" for prescribed drugs.
"If the medicine becomes inaccessible, patients can develop complications much sooner," he said. "The most serious risk is premature death."
One patient requiring testing for an abdominal and pelvic mass recently told Iran International that CT and MRI scans now cost over $100, even with Social Security insurance—the equivalent of a month's pay for many Iranians.
“How are we supposed to pay these costs with such meager incomes?” they asked.
A 33-year-old man said the exorbitant cost of dental treatment has left him without half of his teeth.
“I feel like I’m 60,” he said. “The bitter part is that this humiliating way of life has become normal for me.”
Another Iranian said they feared what would happen if anyone in their family got sick this winter.
“We’re stressed about where we would get the money for treatment," they said, "if God forbid we or our children even catch a cold."
A senior Iranian health official on Tuesday accused the United States of deliberately targeting Iran's medical infrastructure amid a worsening shortage of critical medicines as President Donald Trump's illegal US-Israeli war of choice against Iran drags on.
Iran's pharmaceutical system is straining under US bombing, blockade, and sanctions that have severely disrupted trade and transportation in the Middle East nation of around 90 million people. Iranian officials say shortages of roughly 800 medicines—including dozens of essential drugs—are affecting the treatment of cancer and other serious illnesses.
“The enemy has identified medicine as one of the sensitive areas of the country, and is trying to denigrate and portray Iran’s conditions as unfavorable by releasing content in the press and social media," Deputy Health Minister Mahdi Pirsalehi, who also heads Iran's Food and Drug Administration, told Al Jazeera.
Pirsalehi has said that more than 50 factories and pharmacies have been damaged or destroyed by US and Israeli bombing during the six-month war. The attacks have exacerbated existing shortages.
One gastroenterologist and university professor in Tehran, who spoke to Al Jazeera on condition of anonymity, sounded the alarm on what she called a "staggering" rise in drug prices—including for domestically produced generic medications—caused in significant part by the US naval blockade.
“Reports that rotavirus vaccine imports have been halted because of the maritime blockade—and that influenza vaccines may soon face the same problem—represent a serious and alarming threat to nationwide efforts to prevent vaccine-preventable communicable diseases,” she said.
“Runaway inflation, poverty, and inadequate access to essential food groups among vulnerable populations, including infants, children, and pregnant women, signal the onset and spread of malnutrition,” she added, warning of the risk “of both communicable and noncommunicable diseases, creating a vicious cycle in which malnutrition develops and progressively worsens."
For ordinary Iranians, empty pharmacy shelves, delayed treatments, and prohibitively expensive prescription drugs have become the new normal.
One Iranian pharmaceutical company recently announced price increases for scores of drugs, including a 543% rise in the price of the Alzheimer's medication donepezil, a 308% higher cost for the antibiotic clarithromycin, and a 135% spike in acetaminophen and diphenhydramine syrups, according to reporting by Tasnim News Agency.
Dr. Hassan Nayeb Hashem told Deutsche Welle last month that "for many specific diseases, there is effectively no substitute" for prescribed drugs.
"If the medicine becomes inaccessible, patients can develop complications much sooner," he said. "The most serious risk is premature death."
One patient requiring testing for an abdominal and pelvic mass recently told Iran International that CT and MRI scans now cost over $100, even with Social Security insurance—the equivalent of a month's pay for many Iranians.
“How are we supposed to pay these costs with such meager incomes?” they asked.
A 33-year-old man said the exorbitant cost of dental treatment has left him without half of his teeth.
“I feel like I’m 60,” he said. “The bitter part is that this humiliating way of life has become normal for me.”
Another Iranian said they feared what would happen if anyone in their family got sick this winter.
“We’re stressed about where we would get the money for treatment," they said, "if God forbid we or our children even catch a cold."